We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Noninvasive Device Measures Glucose Levels in Ear

By HospiMedica staff writers
Posted on 12 Dec 2002
A study has found that a handheld device inserted into the ear for about 10 seconds can measure glucose levels with clinically acceptable accuracy. More...
The study was published in the December 2002 issue of Diabetes Care.

The new method and instrument are based on the discovery that natural mid-infrared body emissions change, depending on the glucose concentration of the tissue. The patented device isolates and measures glucose levels from the eardrum by using the body's natural heat emission, averting the need for drawing blood.

"We are utilizing a specific spectral signature of glucose emission in a thermal energy range called mid-infrared, as opposed to others who have attempted to infer glucose levels from measurements in an energy range called near-infrared,” said Carl Malchoff, M.D., Ph.D., associate professor, division of endocrinology and metabolism, University of Connecticut Health Center (Farmington, CT, USA), who conducted the study with Kamal Shoukri, M.D., an assistant professor in the same division.

The monitor is being commercialized by Infratec, Inc. (Wilton, CT, USA), whose founder and president, Janusz Buchert, Ph.D., developed the device. "Infratec's goal is to commercialize a portable, cell phone sized device that will give a direct readout of the person's glucose level without need of a blood sample,” noted Julian Landau, CEO of Infratec.




Related Links:
University of Connecticut Health Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.